Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Fresenius has decided today to terminate the company’s merger agreement with Akorn, due to Akorn’s failure to fulfill several closing conditions.
read more
Freyr has announced the launch of a web platform for Covid-19 driven with real-time information for manufacturers.
read more
Frontage Laboratories announces the acquisition of Concord Biosciences, formerly known as Ricerca Biosciences, a preclinical CRO located near Cleveland, Ohio.
read more
Thursday, September 10, 2015
Frontage, a full service contract research organization (CRO), has announced the appointment of Michael S. Willett, PharmD., RAC as President of its clinical business unit.
read more
Wednesday, September 30, 2015
Frontage, a full service contract research organization (CRO) located in the USA and China, has announced the expansion of its bioanalytical laboratories to meet increased demand for its services from existing and new biopharmaceutical clients.
read more
Thursday, January 29, 2026
Frontage Europe, a wholly owned subsidiary of Frontage Laboratories Inc., has relocated its bioanalytical laboratory to a new 2,500-square-meter facility near Milan, Italy.
read more
Frontage Laboratories, Inc. today announced the acquisition of Ocean Ridge Biosciences.
read more
Frontage Laboratories, Inc., a Contract Research Organization based in Pennsylvania, New Jersey and China, announced on June 4 that its affiliate company, Frontida BioPharm, Inc. acquired certain assets from a wholly owned US subsidiary of Sun Pharma...
read more
Frontage Laboratories today announced that Carlos Orantes has been
appointed Chief Operating Officer. A twenty-year veteran of contract research and life science industries,
he will lead Frontage’s US operations, which comprise a 60,000 square foot...
read more
Frontage Laboratories announced the completion of the acquisition of Teddy Clinical Research Laboratory, a clinical research laboratory service provider in China.
read more
Frontage Laboratories announces two senior appointments to lead its clinical services efforts. George Laskaris has been named Senior Director, Frontage Biometrics Services, bringing more than 20 years of programming, statistical and data management ...
read more
Wednesday, January 03, 2024
Frontage Laboratories, Inc. has successfully completed the acquisition of the Bioanalytical and Drug Metabolism & Pharmacokinetics businesses of Accelera S.r.l (Accelera) through its wholly-owned subsidiary Frontage Europe S.r.l. Accelera, a Contract...
read more
Frontage Laboratories has entered into an agreement to acquire Quintara Discovery. The transaction is expected to close in the third quarter of 2021. Frontage Labs will finance the transaction through the Company's internal resources.
read more
Frontage Laboratories has announced that they have completed a GLP validation of the Simoa HD-1 Analyzer and software along with the interface to Watson LIMS. Data will be generated, processed and stored in a secure environment meeting the compliance...
read more
Frontage Laboratories has established a joint venture with Zhejiang Jiuzhou Pharmaceutical Co., Ltd. to provide enhanced access to high quality and economical API & intermediate development and manufacturing (CDMO) services to new US clients focused ...
read more